NO20006603L - Remedier for hyperkalsemisk krise - Google Patents

Remedier for hyperkalsemisk krise

Info

Publication number
NO20006603L
NO20006603L NO20006603A NO20006603A NO20006603L NO 20006603 L NO20006603 L NO 20006603L NO 20006603 A NO20006603 A NO 20006603A NO 20006603 A NO20006603 A NO 20006603A NO 20006603 L NO20006603 L NO 20006603L
Authority
NO
Norway
Prior art keywords
remedies
hypercalcemic crisis
hypercalcemic
crisis
Prior art date
Application number
NO20006603A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006603D0 (no
Inventor
Koh Sato
Toshiaki Tsunenari
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO20006603D0 publication Critical patent/NO20006603D0/no
Publication of NO20006603L publication Critical patent/NO20006603L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20006603A 1998-06-26 2000-12-22 Remedier for hyperkalsemisk krise NO20006603L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18014398 1998-06-26
PCT/JP1999/003433 WO2000000219A1 (fr) 1998-06-26 1999-06-25 Remedes contre des crises d'hypercalcemie

Publications (2)

Publication Number Publication Date
NO20006603D0 NO20006603D0 (no) 2000-12-22
NO20006603L true NO20006603L (no) 2001-02-20

Family

ID=16078166

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006603A NO20006603L (no) 1998-06-26 2000-12-22 Remedier for hyperkalsemisk krise

Country Status (18)

Country Link
EP (1) EP1090643A4 (cs)
KR (1) KR20010083069A (cs)
CN (1) CN1199693C (cs)
AU (1) AU753131B2 (cs)
BR (1) BR9912223A (cs)
CA (1) CA2332128A1 (cs)
CZ (1) CZ20004753A3 (cs)
HK (1) HK1039454B (cs)
HU (1) HUP0102380A3 (cs)
IL (1) IL140387A0 (cs)
MX (1) MXPA00012770A (cs)
NO (1) NO20006603L (cs)
PL (1) PL345117A1 (cs)
RU (1) RU2004137823A (cs)
SK (1) SK19982000A3 (cs)
TR (1) TR200003768T2 (cs)
TW (1) TWI234464B (cs)
WO (1) WO2000000219A1 (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100335501C (zh) 1996-09-26 2007-09-05 中外制药株式会社 抗人副甲状腺激素相关蛋白的抗体
CA2289910A1 (en) 1997-05-15 1998-11-19 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for cachexia
DK2270147T4 (da) 1999-04-09 2020-08-31 Kyowa Kirin Co Ltd Fremgangsmåde til at kontrollere aktiviteten af immunologisk funktionelt molekyle
EP1197225A4 (en) * 1999-07-02 2006-02-22 Chugai Pharmaceutical Co Ltd AGENTS FOR DISEASES CAUSED BY PTH OR PTHrH
TWI255718B (en) * 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
PL353407A1 (en) * 1999-07-06 2003-11-17 Chugai Seiyaku Kabushiki Kaisha Remedies for drug-resistant hypercalcemia
JP4516711B2 (ja) * 1999-12-28 2010-08-04 中外製薬株式会社 安定な抗体組成物及び注射製剤
WO2001054725A1 (fr) * 2000-01-25 2001-08-02 Chugai Seiyaku Kabushiki Kaisha Remèdes et agents prophylactiques pour maladies dentaires
CA2401357A1 (en) * 2000-02-28 2001-09-07 Chugai Seiyaku Kabushiki Kaisha Tissue degradation inhibitor agent
KR100890873B1 (ko) 2000-03-03 2009-03-31 교와 핫꼬 기린 가부시키가이샤 유전자 재조합 항체 및 이의 항체 단편
EP1283057B2 (en) 2000-04-28 2012-05-30 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitors
EP1849479A1 (en) * 2000-08-16 2007-10-31 Chugai Seiyaku Kabushiki Kaisha Ameliorating agent for symptoms resulting from joint diseases
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
CN100430420C (zh) 2001-08-31 2008-11-05 协和发酵工业株式会社 人cdr-移植抗体及其抗体片段
DK1475101T3 (da) 2002-02-14 2011-01-10 Chugai Pharmaceutical Co Ltd Antistof-holdige farmaceutiske opløsninger
EP4259658A4 (en) * 2020-12-10 2024-12-04 Wuxi Biologics Ireland Limited An antibody against p-cadherin and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04228089A (ja) * 1990-05-15 1992-08-18 Kanegafuchi Chem Ind Co Ltd 高カルシウム血症治療・予防剤
CA2087190A1 (en) * 1990-07-13 1992-01-14 Fred E. Cohen Parathyroid hormone analogues modified at positions
JP3504697B2 (ja) * 1993-09-30 2004-03-08 株式会社先端生命科学研究所 ＰＴＨｒＰアンタゴニスト活性を有するポリペプチド及びそれを含むカルシウム代謝治療薬
DE59705905D1 (de) * 1996-09-26 2002-01-31 Siemens Ag Dampfturbine, dampfturbinenanlage sowie verfahren zur abkühlung einer dampfturbine
CN100335501C (zh) * 1996-09-26 2007-09-05 中外制药株式会社 抗人副甲状腺激素相关蛋白的抗体

Also Published As

Publication number Publication date
RU2004137823A (ru) 2006-06-10
TWI234464B (en) 2005-06-21
AU753131B2 (en) 2002-10-10
AU4289999A (en) 2000-01-17
HUP0102380A2 (hu) 2001-10-28
HK1039454B (zh) 2005-10-21
BR9912223A (pt) 2001-04-24
EP1090643A4 (en) 2004-05-26
CA2332128A1 (en) 2000-01-06
HUP0102380A3 (en) 2004-06-28
CZ20004753A3 (cs) 2002-06-12
KR20010083069A (ko) 2001-08-31
CN1307485A (zh) 2001-08-08
CN1199693C (zh) 2005-05-04
SK19982000A3 (sk) 2001-11-06
EP1090643A1 (en) 2001-04-11
TR200003768T2 (tr) 2001-06-21
NO20006603D0 (no) 2000-12-22
MXPA00012770A (es) 2003-07-14
WO2000000219A1 (fr) 2000-01-06
PL345117A1 (en) 2001-12-03
HK1039454A1 (en) 2002-04-26
IL140387A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
DE69940893D1 (de) Sammelanordnung für medikamente
ID25548A (id) Senyawa-senyawa heterosiklik spiroazabisiklik terbaru
ATE343564T1 (de) Immunoassay für neonicotinyl-insektizide
DE69840955D1 (de) Registrierungsschema für Netzwerk
NO20004849L (no) Offshoreborings-system
NO20003759L (no) Database-anordning
PT1140886E (pt) Metodo para a preparacao de 5- cianoftalida
NO20006603L (no) Remedier for hyperkalsemisk krise
PT1230655E (pt) Po para condensador
DE69915677D1 (de) Vordrucksystem
ID29128A (id) Gen untuk biosintesis epotilon
DK1087992T3 (da) Antithrombotiske forbindelser
DE69925789D1 (de) Bauteil für Bremsen
DE59813401D1 (de) Sterilisierbarer Folienverbund für Verpackungszwecke
DE69907186D1 (de) Schmierungssystem
DE59909955D1 (de) Brennstoffzumess-system
PT1135140E (pt) Utilizacao de ibandronato para a promocao da integracao ossea de endoproteses
ID23196A (id) Gandaran untuk lampuflouresen
DE69906234D1 (de) Gummiervorrichtung
DE69909813D1 (de) Ablenkvorrichtung für schrägseile
DE69927378D1 (de) Bitstopfung für synchrones hdlc
DE69836045D1 (de) Leuchteneinheit für Lichtbandsystem
DE69904544D1 (de) Form für flache Laufflächen
DE59900673D1 (de) Hublade-Bühnensystem
NO20004825D0 (no) Driftsystem for luftfartøy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application